Patent ID: 11891372
Assignee: PFIZER INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. A method of treating a hematologic malignancy in a mammal having said hematologic malignancy, comprising administering to the mammal a pharmaceutical composition comprising a therapeutically effective amount of a crystalline form of 1-(2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate, having the structure:, and having: (a) a powder X-ray diffraction pattern comprising peaks at 2θ values of: 11.6 and 12.1°2θ±0.2°2θ; and (b) a Raman spectrum comprising wavenumber (cm−1) values of: 1612 and 2219 cm−1±2 cm−1, and a pharmaceutically acceptable excipient.